EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effect of efgartigimod IV on immature platelet fraction in primary immune thrombocytopenia in the ADVANCE IV trial

Hanny Al-Samkari iD, Filip Matthijssens, Kaichi Nishiwaki, Francesco Zaja iD, Sylvian Audia, Yoshitaka Miyakawa, Jaume Ayguasanosa, Damien Chimits, Anna Hultberg, Peter Ulrichts

British Journal of Haematology · 2026

DOI: 10.1111/bjh.70749 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2026. Verfasst von Hanny Al-Samkari und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Classical Hematology, Mass General Brigham Cancer Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusett…. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Blood Platelets. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Argenx.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purpura, Thrombocytopenic, IdiopathicBlood PlateletsHumansAutoantibodiesPlatelet CountImmunoglobulin G

Stichwörter der Autor:innen

clinical trialimmune thrombocytopeniaplatelets

Substanzen

AutoantibodiesImmunoglobulin G

Autor:innen und Institutionen

  • Division of Classical Hematology, Mass General Brigham Cancer Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • argenx, Ghent, Belgium.
  • Department of Internal Medicine, The Jikei University Kashiwa Hospital, Kashiwa, Chiba, Japan.
  • Dipartimento Clinico di Scienze Mediche, Università degli Studi di Trieste, Trieste, Italy.
  • UCO Ematologia, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.
  • Department of Internal Medicine and Clinical Immunology, Université Bourgogne Europe, CHU Dijon-Bourgogne, Constitutive Referral Centre for Adult Autoimmune Cytopenia, Dijon, France.

ORCID-Profile: Hanny Al-Samkari, Francesco Zaja

Förderung

  • Argenx

Zitieren

APA

Al-Samkari, H., Matthijssens, F., Nishiwaki, K., Zaja, F., Audia, S., Miyakawa, Y., Ayguasanosa, J., Chimits, D., Hultberg, A., & Ulrichts, P. (2026). Effect of efgartigimod IV on immature platelet fraction in primary immune thrombocytopenia in the ADVANCE IV trial. British Journal of Haematology. https://doi.org/10.1111/bjh.70749

Vancouver

Al-Samkari H, Matthijssens F, Nishiwaki K, Zaja F, Audia S, Miyakawa Y, et al. Effect of efgartigimod IV on immature platelet fraction in primary immune thrombocytopenia in the ADVANCE IV trial. British Journal of Haematology. 2026. doi:10.1111/bjh.70749

BibTeX
@article{AlSamkari2026,
  author = {Al-Samkari, Hanny and Matthijssens, Filip and Nishiwaki, Kaichi and Zaja, Francesco and Audia, Sylvian and Miyakawa, Yoshitaka and Ayguasanosa, Jaume and Chimits, Damien and Hultberg, Anna and Ulrichts, Peter},
  title = {Effect of efgartigimod IV on immature platelet fraction in primary immune thrombocytopenia in the ADVANCE IV trial},
  journal = {British Journal of Haematology},
  year = {2026},
  doi = {10.1111/bjh.70749}
}
Kostenlos starten →